Welcome to Browse Page of Biomarker

This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.

The total number entries retrieved from this search are 44
Please click on Biomarker_ID to view detailed information.
Note: Potential Biomarker with * indicates these signatures are candidate biomarkers extracted from experiments on mice, rat or cell lines and they are not validated on human patients'cohort.
Biomarker IDBiomarkerBiomoleculeSubjectRegulationBiomarker's typeExperimentLevel of significanceSourcePMID
2056Putrescine, spermidine, spermine, N-acetylspermine and N-acetylspermidineMetaboliteHumanUpregulated in the plasma of liver cancer patients than lung cancer patients DiagnosticHCC v/s Normal p < 0.05Urine and Plasma27517900
2057Spermine, followed by N-acetylspermidine, putrescine, cadaverine, spermidine, N-acetylspermine and N-acetylputrescineMetaboliteHumanUpregulated in the urine of liver cancer patients than lung cancer patients DiagnosticHCC v/s Normal p < 0.05Urine and Plasma27517900
2060UracilMetaboliteMiceDownregulated Potential Predictive *Cancer v/s Normal; Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2061cis-Aconitate acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2062D-4-PhosphopantothenateMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2063ProgesteroneMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20645-Thymidylic acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20652-Phospho-d-glyceric acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2066NiacinamideMetaboliteMiceUpregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2067CortisoneMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2068Imidazoleacetic acid ribotideMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20693-Methyl-2-oxovaleric acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2070PseudoephedrineMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20714-PhosphopantothenoylcysteineMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2072Pantetheine 4-phosphateMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2073Hippuric acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20743-Hydroxyanthranilic acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2075GlycineMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2076CreatineMetaboliteMiceUpregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2077CortisolMetaboliteMiceUpregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2078Allantoic acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2079Pantothenic acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2080CreatinineMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2081UreaMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
20825-Hydroxyindoleacetic acidMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2083PhytosphingosineMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.05Urine and Plasma27077962
2084Imidazoleacetic acid ribosideMetaboliteMiceDownregulated Potential Predictive *Drug treated group v/s control group p < 0.01Urine and Plasma27077962
2107Combination of S100A9 and GRNOthersHumanDownregulated in HCC patients Diagnostic and PrognosticNormal vs HCC p < 0.001Urine26675302
2113Alpha-ketoglutaricMetaboliteHumanThe concentrations of α-KG in diabetic II and liver cancer urine samples were significantly lower than those from healthy people. DiagnosticNormal vs cancer p < 0.05Urine25871588
2114pyruvic acidMetaboliteHumanThe concentrations of PA in diabetic II and liver cancer urine samples were significantly lower than those from healthy people. DiagnosticNormal vs cancer p < 0.05Urine25871588
2151DJ-1ProteinHumanUpregulated in HCC DiagnosticNormal vs HCC with Hepatitis C and without Hepatitis C p < 0.05Urine23074380
2152CAF-1ProteinHumanUpregulated in HCC DiagnosticNormal vs HCC with Hepatitis C and without Hepatitis C p < 0.05Urine23074380
2153HSP60ProteinHumanUpregulated in HCC DiagnosticNormal vs HCC with Hepatitis C and without Hepatitis C p < 0.05Urine23074380
2154DJ-1, CAF-1ProteinHumanUpregulated in HCC DiagnosticNormal vs HCC with Hepatitis C and without Hepatitis C p < 0.05Urine23074380
2155DJ-1, HSP60ProteinHumanUpregulated in HCC DiagnosticNormal vs HCC with Hepatitis C and without Hepatitis C p < 0.05Urine23074380
2156CAF-1, HSP60ProteinHumanUpregulated in HCC DiagnosticNormal vs HCC with Hepatitis C and without Hepatitis C p < 0.05Urine23074380
2157DJ-1, CAF-1, HSP60ProteinHumanUpregulated in HCC DiagnosticNormal vs HCC with Hepatitis C and without Hepatitis C p < 0.05Urine23074380
2200AFP, (with cut off 0.9 of AFP in serum )ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2201BMK, (with cut off 0.40 BMK in Urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2202AFP, BMK, (with cut off 1.25 of AFP in serum and 0.25 BMK in urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2203AFP, BMK, (with cut off 1.20 of AFP in serum and 0.27 BMK in urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2204AFP, BMK, (with cut off 0.90 of AFP in serum and 0.40 BMK in urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2205AFP, BMK, (with cut off 1.65 of AFP in serum and 0.40 BMK n urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526
2206AFP, BMK, (with cut off 0.9 of AFP in serum and 0.75 BMK in urine)ProteinHumanNA DiagnosticHCC v/s Non-HCC NASerum and Urine29152526

         Raghava's group    CancerCSP    CancerSPP    CancerPDF    CancerTSP    CancerLSP    HCCPred   

Scroll to Top